Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 28 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

43%

12 trials in Phase 3/4

Results Transparency

26%

6 of 23 completed with results

Key Signals

6 with results100% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (8)
P 1 (1)
P 2 (3)
P 3 (10)
P 4 (2)

Trial Status

Completed23
Withdrawn2
Unknown1
Recruiting1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT05538689Phase 4WithdrawnPrimary

Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)

NCT07611331Not ApplicableCompleted

Single-Layer Versus Double-Layer Uterine Closure After Primary Cesarean Section

NCT07083635Phase 2Recruiting

Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users

NCT06802198Not ApplicableNot Yet Recruiting

A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes

NCT02311478Not ApplicableCompleted

Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users

NCT01865929Not ApplicableCompleted

Minimally Invasive Benign Hysterectomy

NCT05406960Not ApplicableCompleted

Therapeutic Effect of Herbal Infusion on Menometrorrhagia

NCT00563576Not ApplicableCompletedPrimary

Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

NCT03121560Not ApplicableCompletedPrimary

Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation

NCT01918072CompletedPrimary

Controlled Trial of Tele-Support and Education for Womens Health Care in CBOCs

NCT02824224Phase 4Completed

Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

NCT03230994Unknown

Cooperative Adenomyosis Network

NCT03250884Completed

Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test.

NCT01793584Not ApplicableCompletedPrimary

Surgical Success After Laparoscopic vs Abdominal Hysterectomy

NCT01557023Phase 3WithdrawnPrimary

Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol

NCT01638923Phase 3CompletedPrimary

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

NCT00307801Phase 3CompletedPrimary

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

NCT00293059Phase 3CompletedPrimary

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

NCT01647360Completed

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

NCT01436513Phase 1Completed

A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

Scroll to load more

Research Network

Activity Timeline